Also found in: Dictionary, Medical, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for Prevacid

antacid (trade name Prevacid) that suppresses acid secretion in the stomach

References in periodicals archive ?
The FDA approved Enteryx for use in patients with GERD symptoms who require and respond to proton pump inhibitor medications, such as AstraZeneca Plc's Prilosec and Nexium and TAP Pharmaceutical Products' Prevacid.
Have now been taking a Prevacid 30 mg capsule daily (prescription), and it works wonders.
For example, Prevacid, a drug used to treat heartburn, costs about $121 in the U.
The subpoena requested information about Lupron, a TAP drug given to treat endometriosis, and Prevacid, used to treat ulcers.
to treat acid-related disorders (such as gastroesophageal reflux disease [GERD], erosive esophagitis, active benign gastric ulcers and other conditions associated with overproduction of stomach acid), Prevacid is the first proton pump inhibitor (PPI) available in this formulation.
The first line of defense are usually acid suppression drugs, such as Prevacid, Nexium, and Prilosec, which can lower gastric acid production and relieve symptoms.
There are OTC versions of Prilosec, Zegerid, and Prevacid.
Prevacid 24HR has an average retail price starting at $11.
s Prevacid acid reflux drug and Johnson & Johnson's (New Brunswick NJ) Topamax for epilepsy.
Our daughter's current medications are Tegretol, Klonopin, Depekene, Claratin, Mir-a-lax Prevacid, and Centrum liquid.
Doctors placed blame on stomach acid and prescribed Prevacid, which gives me some relief.
If people have had heartburn for more than five years, if they have it several times a week, if it's severe enough to require a strong medicine like Prevacid or Prilosec, or if it's their main [reason] for going to the doctor, they should have an endoscopy and a biopsy," says Cohen.
Lansoprazole Delayed-Release Rx Capsules are AB rated to Prevacid, a Proton Pump Inhibitor (PPI) drug marketed by Takeda Pharmaceuticals, USA.
Takeda said the FDA pushed back the deadline for possible approval of TAK-390MR, a possible successor to its Prevacid ulcer drug, by three months to Jan.